China Biotech Innovation ETF (CHB)
|Day's Range||16.10 - 16.36|
|Inception Date||Sep 22, 2020|
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index (underlying index). The fund invests at least 80% of its total assets, plus borrowings for investments purposes (if any), in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are directly involved in China's biotechnology industry. It is non-diversified.
Top 10 Holdings61.52% of assets
|WALVAX BIOTECHNOLOGY CO-A||N/A||10.36%|
|WUXI BIOLOGICS CAYMAN INC||2269.HK||10.15%|
|GENSCRIPT BIOTECH CORP||1548.HK||4.13%|
|BGI GENOMICS CO LTD-A||N/A||3.77%|
|Jun 29, 2021||$0.00||Jul 8, 2021|
As China continues to lead the global recovery, one area to keep a close eye on is biotechnology and the Global X China Biotech Innovation ETF (CHB). CHB seeks to provide investment results that corresp...
Investing in biotech stocks may feel daunting to many investors, but these three stocks deserve to be on your watchlist. The post 3 Biotech Stocks With Eye-Catching Pipelines appeared first on InvestorP...
All around the world, economic superpowers are vying to be the first to develop a vaccine for Covid-19. China is an obvious contender given that the country was the epicenter of the virus and their succ...